Does declining ovarian reserve and hormonal variability in perimenopause cause irregular cycles and increased mood and sleep disturbance?

The perimenopausal transition is defined by a progressive decline in the primordial follicle pool, which triggers significant neuroendocrine instability. This physiological shift is not a simple linear decline but a period of intense hormonal variability that fundamentally impacts physical and mental well-being.

Clinical and physiological findings

Research from major longitudinal studies, such as the SWAN and Penn Ovarian Aging Study, confirms that declining ovarian reserve—marked by decreasing Anti-Müllerian Hormone (AMH) and Inhibin B—leads to unpredictable menstrual cycles.

• Cycle Irregularity: As follicle numbers drop, the pituitary gland increases Follicle-Stimulating Hormone (FSH) to compensate. This creates erratic follicle development, leading to shortened cycles in early perimenopause and prolonged, anovulatory cycles as the transition progresses.
• Mood and Sleep: Data indicate a 2- to 4-fold increased risk for depressive symptoms during this window. Clinical evidence shows that it is often the variability of estrogen, rather than the absolute level, that triggers these symptoms. Sleep fragmentation is also highly prevalent, with up to 40-60% of perimenopausal women reporting disturbances.

Mechanistic explanations

The connection between hormonal shifts and symptoms is rooted in the sensitivity of the central nervous system to estrogen and progesterone fluctuations.

• Neurotransmitter Modulation: Estrogen influences the synthesis and receptor binding of serotonin and norepinephrine. Rapid estrogen withdrawal destabilizes these pathways, particularly in the limbic system, leading to mood vulnerability.
• GABAergic Signaling: Progesterone and its metabolite, allopregnanolone, are potent modulators of $GABA_A$ receptors, which provide inhibitory "calming" effects. Erratic progesterone levels during perimenopause disrupt this system, contributing to heightened anxiety and sleep-onset difficulties.
• Thermoregulation: Fluctuating estrogen levels also narrow the "thermoneutral zone" in the hypothalamus. This triggers vasomotor symptoms (night sweats), which directly cause nocturnal awakenings and exacerbate cognitive and mood disturbances.

Bottom line

The perimenopausal transition involves a measurable decline in ovarian reserve that destabilizes the hypothalamic-pituitary-ovarian axis. This instability creates a state of neuroendocrine flux, directly contributing to cycle irregularity, mood disorders, and sleep disturbances through disrupted serotonin and GABA signaling.